| 1 |
35173877 | Effect of various doses of rosuvastatin in the treatment of elderly patients with unstable angina pectoris. | 2022 |
1 |
| 2 |
33652637 | Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects. | 2021 Feb 26 |
2 |
| 3 |
33913752 | The Effect of Rosuvastatin on Plasma/Serum Levels of High-Sensitivity C-Reactive Protein, Interleukin-6, and D-Dimer in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. | 2021 Nov |
1 |
| 4 |
34217687 | Pelargonic acid vanillylamide and rosuvastatin protect against oxidized low-density lipoprotein-induced endothelial dysfunction by inhibiting the NF-κB/NLRP3 pathway and improving cell-cell junctions. | 2021 Aug 25 |
1 |
| 5 |
34956579 | Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease. | 2021 |
2 |
| 6 |
32428019 | Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India. | 2020 |
1 |
| 7 |
32652935 | Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups. | 2020 Jul 11 |
1 |
| 8 |
33224343 | Statins and C-reactive protein: in silico evidence on direct interaction. | 2020 |
2 |
| 9 |
30674312 | Effectiveness of long-term using statins in COPD - a network meta-analysis. | 2019 Jan 23 |
1 |
| 10 |
30790446 | Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study. | 2019 Nov 1 |
2 |
| 11 |
26271127 | Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia. | 2016 Jul |
4 |
| 12 |
26747436 | Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials. | 2016 Apr |
1 |
| 13 |
27058799 | Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis. | 2016 |
1 |
| 14 |
27144849 | Perioperative Rosuvastatin in Cardiac Surgery. | 2016 May 5 |
1 |
| 15 |
27756037 | Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes. | 2016 Dec 15 |
1 |
| 16 |
25536316 | Rosuvastatin ameliorates inflammation, renal fat accumulation, and kidney injury in transgenic spontaneously hypertensive rats expressing human C-reactive protein. | 2015 |
2 |
| 17 |
25771851 | Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis. | 2015 Jun |
2 |
| 18 |
26311995 | Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome. | 2015 Jul-Sep |
4 |
| 19 |
24304551 | Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study). | 2014 Feb 1 |
1 |
| 20 |
24410968 | Rosuvastatin can block pro-inflammatory actions of transgenic human C-reactive protein without reducing its circulating levels. | 2014 Apr |
5 |
| 21 |
24614628 | Difference in statin effects on neointimal coverage after implantation of drug-eluting stents. | 2014 Jun |
1 |
| 22 |
25159238 | Effect of rosuvastatin on coronary flow reserve in patients with systemic hypertension. | 2014 Oct 15 |
1 |
| 23 |
25278982 | Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy. | 2014 Sep |
1 |
| 24 |
22573476 | Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study. | 2013 Jan |
1 |
| 25 |
23600368 | Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial. | 2013 Jul |
1 |
| 26 |
24008003 | Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study. | 2013 |
2 |
| 27 |
21782402 | Prevalence of low LDL-cholesterol levels and elevated high-sensitivity C-reactive protein levels in apparently healthy Korean adults. | 2012 Dec |
2 |
| 28 |
21983163 | Impact of 10 mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers. | 2012 Jan 18 |
1 |
| 29 |
22230323 | Pharmacogenetic determinants of statin-induced reductions in C-reactive protein. | 2012 Feb 1 |
3 |
| 30 |
22278047 | Statins, inflammation and deep vein thrombosis: a systematic review. | 2012 May |
2 |
| 31 |
22555227 | Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study. | 2012 May |
5 |
| 32 |
22687786 | Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis. | 2012 |
2 |
| 33 |
22697388 | Recent clinical studies of the effects of lipid-modifying therapies. | 2012 Jul 1 |
1 |
| 34 |
20471117 | 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome. | 2011 Jan 7 |
1 |
| 35 |
20971747 | Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities. | 2011 Jan |
1 |
| 36 |
21046291 | Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? | 2011 Feb |
1 |
| 37 |
21257003 | Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. | 2011 Feb 1 |
3 |
| 38 |
21310313 | The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. | 2011 Feb 15 |
1 |
| 39 |
21422984 | High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors. | 2011 May 15 |
1 |
| 40 |
21492764 | Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). | 2011 Apr 19 |
1 |
| 41 |
21562509 | Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein. | 2011 Jul |
1 |
| 42 |
21641360 | Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis. | 2011 Jun |
3 |
| 43 |
21742096 | Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. | 2011 Jul |
1 |
| 44 |
21792541 | C-reactive protein, statins and the risk of vascular events: a better understanding. | 2011 Dec |
1 |
| 45 |
21856482 | Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. | 2011 Aug 20 |
1 |
| 46 |
21860701 | JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses. | 2011 Jul 26 |
1 |
| 47 |
21921413 | Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy. | 2011 |
1 |
| 48 |
19351576 | Serum levels of C-reactive protein in patients with stable coronary artery disease: JUPITER in perspective. | 2010 Oct 29 |
1 |
| 49 |
20026779 | Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). | 2010 Jan 5 |
2 |
| 50 |
20102894 | Eligibility for statin therapy by the JUPITER trial criteria and subsequent mortality. | 2010 Jan 1 |
2 |